Blockchain Registration Transaction Record

Scinai Immunotherapeutics' PC111 Shows Promise in Treating Dermatological Conditions

Scinai Immunotherapeutics announces PC111's potential in treating pemphigus and SJS/TEN, offering a non-immunosuppressive solution. A breakthrough in dermatological treatment.

Scinai Immunotherapeutics' PC111 Shows Promise in Treating Dermatological Conditions

This news is significant because it highlights a potential breakthrough in treating severe dermatological conditions like pemphigus and SJS/TEN with a non-immunosuppressive approach. The development of PC111 by Scinai Immunotherapeutics could offer new hope to patients suffering from these life-threatening conditions, marking a pivotal advancement in medical science and biopharmaceutical innovation.

BlockchainDetails
Contract Address0xeA2912a8DA1CD48401b10cB283585874d98098F4
Transaction ID0x47c20021114e1f62e11cbdd7f204e6cd38aabb01d5f7f347da4b6f67cac256d4
Account0xdBdE7c76e403a5923F3dD4F050Dbbf5c2077BB20
Chainpolygon-main
NewsRamp Digital FingerprinticonbjmI-6d573fe444d98e37349a3d7f8bc92eff